Three consecutive rounds of co-culture of CAR T cells with OV-90 target cells allowed for the identification of CAR candidates, which were able to mediate repeated killing of FOLR1-expressing cells as an in vitro surrogate approach for effective reduction of tumor burden (Figure 4A). Here, FOLR1 is linked to neoplasm.